1. Home
  2. MCD vs JNJ Comparison

MCD vs JNJ Comparison

Compare MCD & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MCD

McDonald's Corporation

HOLD

Current Price

$268.27

Market Cap

204.6B

ML Signal

HOLD

Logo Johnson & Johnson

JNJ

Johnson & Johnson

HOLD

Current Price

$253.95

Market Cap

542.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCD
JNJ
Founded
1940
1886
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
204.6B
542.4B
IPO Year
1996
2003

Fundamental Metrics

Financial Performance
Metric
MCD
JNJ
Price
$268.27
$253.95
Analyst Decision
Buy
Buy
Analyst Count
29
20
Target Price
$344.17
$238.20
AVG Volume (30 Days)
4.2M
7.7M
Earning Date
05-07-2026
04-14-2026
Dividend Yield
2.56%
2.36%
EPS Growth
4.92
90.50
EPS
2.78
2.14
Revenue
$26,885,000,000.00
N/A
Revenue This Year
$7.65
$6.63
Revenue Next Year
$6.00
$7.43
P/E Ratio
$95.24
$114.54
Revenue Growth
3.72
N/A
52 Week Low
$264.60
$151.52
52 Week High
$341.75
$251.71

Technical Indicators

Market Signals
Indicator
MCD
JNJ
Relative Strength Index (RSI) 37.55 71.37
Support Level N/A $233.83
Resistance Level $311.08 N/A
Average True Range (ATR) 5.46 5.06
MACD -1.21 1.69
Stochastic Oscillator 15.06 97.58

Price Performance

Historical Comparison
MCD
JNJ

About MCD McDonald's Corporation

McDonald's is the world's largest restaurant brand, with nearly $139 billion in systemwide sales across more than 45,000 restaurants and over 100 markets. The quick-service chain built its early reputation on speed, consistency, and affordable hamburgers, and today its global menu spans burgers, chicken, breakfast, and beverages that have helped popularize American fast-food cuisine worldwide. The firm derives the bulk of its revenue from franchise royalties and rent (about 62%), with the remainder stemming from company-operated restaurants across three segments: the United States (39% of systemwide sales), international operated markets (35%), and international developmental/licensed markets (26%).

About JNJ Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Share on Social Networks: